Skip to search
Skip to main content
Back to Search
Start Over
Survival, neurocognitive function, and health-related quality of life outcomes after rituximab-methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final Results of the HOVON 105 / ALLG NHL 24 Study
Authors :
MS Hematologie Cancer Infection & Immunity Regenerative Medicine and Stem Cells Neurologen Bromberg, Jacoline E C Issa, Samar van der Holt, Bronno van der Meulen, Matthijs Dirven, Linda Minnema, Monique C Seute, Tatjana Durian, Marc Cull, Gavin van der Poel, Marjolein W M Stevens, Wendy B C Zijlstra, Josee M Brandsma, Dieta Nijland, Marcel Mason, Kylie D Beeker, Aart Abrahamse-Testroote, Martine C J van den Bent, Martin J de Jong, Daphne Doorduijn, Jeanette K MS Hematologie Cancer Infection & Immunity Regenerative Medicine and Stem Cells Neurologen Bromberg, Jacoline E C Issa, Samar van der Holt, Bronno van der Meulen, Matthijs Dirven, Linda Minnema, Monique C Seute, Tatjana Durian, Marc Cull, Gavin van der Poel, Marjolein W M Stevens, Wendy B C Zijlstra, Josee M Brandsma, Dieta Nijland, Marcel Mason, Kylie D Beeker, Aart Abrahamse-Testroote, Martine C J van den Bent, Martin J de Jong, Daphne Doorduijn, Jeanette K
Publication Year :
2024
Details
Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1432122633
Document Type :
Electronic Resource